news & events

Check out what we’ve been up to and where we can connect!

News

Evaluation of baricitinib versus dexamethasone for adults hospitalized with COVID-19 in the global ACTT-4 study

September 7, 2022
The global ACTT-4 study, supported by FHI Clinical, evaluated baricitinib vs dexamethasone for adults hospitalized with COVID-19. This trial is the fourth and final stage in a series of phase 3, randomized, double-blind, placebo-controlled trials to evaluate the clinical efficacy and safety of investigational therapeutic agents in hospitalized adults with laboratory-confirmed COVID-19.

Read more »

Events

Bio-Europe Spring

March 20-23, 2023
Attending Bio-Europe Spring? Schedule a meeting with an FHI Clinical team member who will be attending. We’d love to talk about future partnering opportunities!

Read more »

7th AMR Conference

March 16-17, 2023
Attending the 7th AMR Conference? Schedule a meeting with an FHI Clinical team member who will be attending to chat about how our experience with AMR can be used to support your upcoming trials.

Read more »

SCOPE 2023

February 6-9, 2023
Attending SCOPE? Schedule a meeting with an FHI Clinical team member who will be attending.

Read more »

ASTMH 2022

October 30 – November 3, 2022
Attending the ASTMH Annual Meeting 2022? Stop by our booth to chat with members of our team will be available to talk about your ongoing and future projects.

Read more »